Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Smits

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
American Journal of Human Genetics|January 25, 2022
Midbrain organoids mimic early embryonic neurodevelopment and recapitulate LRRK2-p.Gly2019Ser-associated gene expressionAlise Zagare, Kyriaki Barmpa, Semra Smajic, et al.
Cell and Tissue Research|August 2, 2020
Single-cell transcriptomics reveals multiple neuronal cell types in human midbrain-specific organoidsLisa M Smits, Stefano Magni, Kaoru Kinugawa, et al.
The Analyst|February 24, 2021
Monitoring the neurotransmitter release of human midbrain organoids using a redox cycling microsensor as a novel tool for personalized Parkinson's disease modelling and drug screeningCristian Zanetti, Sarah Spitz, Emanuel Berger, et al.
Parkinsonism & Related Disorders|June 14, 2020
Machine learning-assisted neurotoxicity prediction in human midbrain organoidsAnna S Monzel, Kathrin Hemmer, Tony Kaoma, et al.
Acta Neuropathologica Communications|July 3, 2018
Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicityAsad Jan, Brandon Jansonius, Alberto Delaidelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2017
Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's diseaseAthanasios D Spathis, Xenophon Asvos, Despina Ziavra, et al.
Stem Cell Reports|April 19, 2017
Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem CellsAnna S Monzel, Lisa M Smits, Kathrin Hemmer, et al.
NPJ Parkinson'S Disease|April 10, 2019
Modeling Parkinson's disease in midbrain-like organoidsLisa M Smits, Lydia Reinhardt, Peter Reinhardt, et al.
Cell Reports|October 23, 2021
The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1Jonas Walter, Silvia Bolognin, Suresh K Poovathingal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 12, 2021
Parkinson's Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-β-Cyclodextrin TreatmentJavier Jarazo, Kyriaki Barmpa, Jennifer Modamio, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Human Genetics|January 25, 2022
Midbrain organoids mimic early embryonic neurodevelopment and recapitulate LRRK2-p.Gly2019Ser-associated gene expressionAlise Zagare, Kyriaki Barmpa, Semra Smajic, et al.
Cell and Tissue Research|August 2, 2020
Single-cell transcriptomics reveals multiple neuronal cell types in human midbrain-specific organoidsLisa M Smits, Stefano Magni, Kaoru Kinugawa, et al.
The Analyst|February 24, 2021
Monitoring the neurotransmitter release of human midbrain organoids using a redox cycling microsensor as a novel tool for personalized Parkinson's disease modelling and drug screeningCristian Zanetti, Sarah Spitz, Emanuel Berger, et al.
Parkinsonism & Related Disorders|June 14, 2020
Machine learning-assisted neurotoxicity prediction in human midbrain organoidsAnna S Monzel, Kathrin Hemmer, Tony Kaoma, et al.
Acta Neuropathologica Communications|July 3, 2018
Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicityAsad Jan, Brandon Jansonius, Alberto Delaidelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2017
Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's diseaseAthanasios D Spathis, Xenophon Asvos, Despina Ziavra, et al.
Stem Cell Reports|April 19, 2017
Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem CellsAnna S Monzel, Lisa M Smits, Kathrin Hemmer, et al.
NPJ Parkinson'S Disease|April 10, 2019
Modeling Parkinson's disease in midbrain-like organoidsLisa M Smits, Lydia Reinhardt, Peter Reinhardt, et al.
Cell Reports|October 23, 2021
The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1Jonas Walter, Silvia Bolognin, Suresh K Poovathingal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 12, 2021
Parkinson's Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-β-Cyclodextrin TreatmentJavier Jarazo, Kyriaki Barmpa, Jennifer Modamio, et al.
Pageof 1